We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves First Dementia-Related Psychosis Drug
FDA Approves First Dementia-Related Psychosis Drug
The FDA has approved Acadia Pharmaceuticals’ Nuplazid to treat Parkinson’s disease in patients suffering from psychosis-related hallucinations and delusions.